Navigation Links
Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer
Date:10/17/2007

novel agents for the treatment of cancer with liver cancer as the first therapeutic indication. The Company is exploring both naked anti-HAAH antibodies as well as HAAH antibodies conjugated to chemotherapeutic agents and toxins. PAN-622 is an all-human sequence anti- HAAH monoclonal antibody that has demonstrated excellent efficacy in animals, and is currently in development as a cancer therapeutic.

About Panacea Pharmaceuticals, Inc.

Panacea Pharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on the development and commercialization of therapeutics and diagnostics for diseases with substantial, unmet clinical needs. The Company's product development strategy is based on novel therapeutic agents and approaches for cancer treatment, as well as acute and chronic neurodegenerative conditions, such as hypoxia-induced neurological insult, Parkinson's Disease, and Alzheimer's Disease. Panacea has an extensive patent portfolio covering its neurodegenerative and oncology technologies. Panacea Laboratories is a division of Panacea Pharmaceuticals, Inc.

More information about the Company is available at http://www.PanaceaPharma.com.

Except for historical information presented in this press release, matters discussed herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on the opinions and estimates of management only as of the date of this release and are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance, or achievements expressed or implied by such statements. Factors that might cause such a difference include, but are not limited to, uncertainties related to our access to capital, the progress, costs, and results of any clinical trials undertaken by us, progress of our research a
'/>"/>

SOURCE Panacea Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... Applied Biosystems, part of Life Technologie...ive life science research and discovery solutions,...ration genomic analysis, the SOLiD™ System, ...Year for 2008 by The Scientist, a leading scientif...y. In making the announcement of the first-ever Li...
(Date:12/3/2008)...nown dangers of first- and secondhand smoke, an es...are smokers. Exposure of a developing baby to har...ffects an estimated 420,000 newborns each year and...in the first study of its kind, a team of research... umbilical cord blood to better understand the fet...
(Date:12/3/2008)...HIA, Dec. 3 GlaxoSmithKl... waiving a condition relating to a,pending lawsui...hase all of,the outstanding shares of common stoc...), for $1.30 per share in cash without interest an...t is a condition to the completion of the tender o...
(Date:12/3/2008)...December 3 Cellectricon, a leading...ry, today announced the,signing of a collaborativ...in,the UK, manufacturers of advanced automated sy...h throughput screening applications. Under the agr...naflow(R)HT System, Cellectricon,s,next generatio...
Breaking Biology Technology: Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 2Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 3
...an landscape, Google is achieving a similar posi... Google,s brand and services don,t touch my life a...business owner. , ,The seven-year-old company, wh... ads, went public just 15 months ago at $85 and cl...apitalization is over $109 billion, making it the ...
...nnounced a new eHealth Care Quality and Patient Sa...n of electronic medical records in Wisconsin. , ,"... of information technology at the most important p...," Doyle said in a statement, citing statistics sh...ry or redundant. "This board will develop a road m...
...hursday his veto of AB 499, which would have outla...e bill would outlaw not only cloning for reproduct...utic or research cloning, in which an embryo is cr...r the purposes of harvesting stem cells during the...destroyed in the process. , ,Penalties for violati...
...ouncil has teamed with JobSightUSA , a top-ranked...st, to match job seekers with positions based on s...bSightUSA helps companies that are considering loc...d hire professionals, while also assisting former ... state. The site enables professional jobseekers t...
Other Biology Technology:Are you a citizen of the "Google Nation?" 2Are you a citizen of the "Google Nation?" 3Wisconsin pushes for adoption of electronic health records 2Doyle vetoes cloning ban 2
(Date:12/4/2008)...men, often touting their intelligence and their hi...g University and Oxford University that studied 40...e partners. , Research in the theory of evolutio... men and women choose their partners. Among the m...is on attractive appearance, whereas resources and...
(Date:12/3/2008)...ay, it,s easy to forget that a dam and pond stood ...n,s Franbrook Farm Research Station in southwester... and acres of plants, both native and weedy, now c...ess, memories of the dam remain, and by digging in...are now unearthing them. Writing in a special issu...
(Date:12/3/2008)...they may not help improve a person,s golf game, st...k about the local country club in the near future,... "There are more than 17,000 golf courses in the U... land is not used for playing," said Ray Semlitsch... of Arts and Science. "These managed green spaces ...
(Date:12/3/2008)... trials that individuals can respond just as well ...On the other hand, it is difficult to explain why ...eam of researchers from Uppsala University and Got...at can impact the placebo effect and a mechanism i...o placebos. , The study, published in Journal o...
Breaking Biology News(10 mins):Myth about 'dirty old men' supported by science 2Researchers examine role of soil patterns in dam restoration 2Researchers examine role of soil patterns in dam restoration 3Golf course: Playing fields, wildlife sanctuaries or both 2Genes determine whether sugar pills work 2Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 1Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 2Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 3Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 4Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 5Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 6Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 7Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 8Kiwa Bio Tech 2nd Quarter Revenues Increase 61 7 25 to 243 Million Six Month Revenues Top 245 2 Million 7080 9Ethicon Endo Surgery to Acquire SurgRx 7075 1Ethicon Endo Surgery to Acquire SurgRx 7075 2Ethicon Endo Surgery to Acquire SurgRx 7075 3Lack of Vitamin D Boosts Death Risk 25272 1Lack of Vitamin D Boosts Death Risk 25272 2Lack of Vitamin D Boosts Death Risk 25272 3Research translates into successful community practice to improve elder health 25267 1Research translates into successful community practice to improve elder health 25267 2
....,announced plans to make eight new GeneChip(R) pl...part of its Consortia Program, including,canine, R...ica, tomato,citrus, poplar and sugar cane. More t... and Animal Genome Conference XIII in San Diego,C...nder the Consortia,Program. , Some of the studies ...
...ability of,HIV infection per act of heterosexual s...s has found that uncircumcised men have more,than ...d men.,In the study, published in the Feb. 15 issu...able online, Jared Baeten and colleagues,from the ...data from a,group of male Kenyan truckers and, usi...
...ng,nanoparticle and gene silencing technologies th... -- a virus associated with severe,bronchitis and ...rida,researchers found. The study was reported in ...ine.,RSV infects lung cells and can be life-threat...e with compromised immune systems. No,vaccine or w...
... replicated hepatitis C virus (HCV) in the laborat...will allow researchers to better study the life cy...l antiviral compounds, which may lead to new thera...tion with HCV. Scientists at the National Institut...IDDK), one of the National Institutes of Health (N...
Other Biology News:Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering 2Male circumcision reduces risk of HIV transmission from women to men 2Novel antiviral technology inhibits RSV infection in mice 2Scientists Replicate Hepatitis C Virus in Laboratory 2
Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures
...ueous solution. Cleaves a-(1-3)- and a(1-6)-lin...carbohydrates and glycoproteins. It is particularl...conditions where the pH must be neutral or above, ... One unit will hydrolyze 1 mole of p-nitrophenyl a...
...for human cardiac troponin subunit T, a 31kDa prot...s responsible for contraction of cardiac muscle. I... human cells. It also cross-reacts with human skel...hly purified human cardiac troponin T This antib...
Biology Products: